Analyze Diet

Carbon dioxide laser ablation for treatment of limbal squamous cell carcinoma in horses.

Abstract: Limbal squamous cell carcinoma in 4 horses was treated successfully, using carbon dioxide laser ablation. Tumors were removed, with minimal to no postoperative inflammation or discomfort to the horses. Carbon dioxide laser ablation represents a promising new option in the treatment of limbal squamous cell carcinoma in horses.
Publication Date: 1990-02-01 PubMed ID: 2298673
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper discusses the use of carbon dioxide laser ablation as an effective method in treating limbal squamous cell carcinoma in horses.

Overview of the Research

  • The study focused on applying carbon dioxide laser ablation, a type of treatment usually used on neoplasias, for treating limbal squamous cell carcinoma in horses. This carcinoma is a common eyewall tumor in horses that can damage the eye severely if left untreated.
  • Four horses with diagnosed limbal squamous cell carcinoma were included as samples for this study.

Procedure and Results

  • The treatment using carbon dioxide laser ablation was applied to these four horses. The tumors were exposed to the laser, which emits light at a specific wavelength highly absorbable by water. Upon absorption, the water rapidly heats up and vaporizes the nearby tissues, thus ablating the tumor.
  • The method was found to be successful as it managed to remove the tumors without causing significant postoperative inflammation or discomfort to the horses. This suggests that the horses were able to tolerate the procedure well.

Conclusions

  • Using carbon dioxide laser ablation for treating limbal squamous cell carcinoma in horses emerged as a promising form of treatment in this study.
  • This technique presented a new potential alternative for curing horses suffering from this eye wall tumor, especially since the process did not induce considerable postoperative inflammation or discomfort.
  • Though the study only demonstrated success in treating limbal squamous cell carcinoma in four horses using carbon dioxide laser ablation, it provides a good basis for larger-scale studies on the effectiveness of this treatment approach.

Cite This Article

APA
English RV, Nasisse MP, Davidson MG. (1990). Carbon dioxide laser ablation for treatment of limbal squamous cell carcinoma in horses. J Am Vet Med Assoc, 196(3), 439-442.

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 196
Issue: 3
Pages: 439-442

Researcher Affiliations

English, R V
  • Department of Companion Animal, College of Veterinary Medicine, North Carolina State University, Raleigh 27606.
Nasisse, M P
    Davidson, M G

      MeSH Terms

      • Animals
      • Carcinoma, Squamous Cell / surgery
      • Carcinoma, Squamous Cell / veterinary
      • Conjunctival Neoplasms / surgery
      • Conjunctival Neoplasms / veterinary
      • Corneal Diseases / surgery
      • Corneal Diseases / veterinary
      • Eye Neoplasms / surgery
      • Eye Neoplasms / veterinary
      • Female
      • Horse Diseases / surgery
      • Horses
      • Laser Therapy / veterinary
      • Male

      Citations

      This article has been cited 2 times.
      1. Wotman KL, Chow L, Martabano B, Pezzanite LM, Dow S. Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia.. Cancer Immunol Immunother 2023 May;72(5):1185-1198.
        doi: 10.1007/s00262-022-03321-2pubmed: 36367558google scholar: lookup
      2. Scheck JL. Treatment of an ocular squamous cell carcinoma in a stallion with atrial fibrillation.. Can Vet J 2005 Oct;46(10):922-4.
        pubmed: 16454385